Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes

NCT05403502 is registered in ClinicalTrials.gov with Tandem Diabetes Care, Inc. as lead sponsor.

NCT NCT05403502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05403502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes
Lead sponsor
Tandem Diabetes Care, Inc.
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2022
Completion date
August 2, 2023
Enrollment
183 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes